A Model for Continuous Care of Fragile Patients
Ориентир для пациента и семьи
Простыми словами
Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.
- Что изучают
- В протоколе указаны: Telemedicine-Based Functional Monitoring.
- Кому может быть актуально
- Состояния в реестре: Neurological Disorders, Orthopedic Disorders, Functional Decline, Fragile and More Vulnerable. Базовые параметры: от 18 лет · Все.
- Что важно проверить
- Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
- Где проводится
- Италия
- Следующий шаг
- Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Не всё понятно в терминах? Прочитайте наш гид для пациентов →
Официальное название
Un Modello di Presa in Carico Continua Del Paziente Fragile
Обзор
This observational study aims to monitor functional status and identify potential declines in the functioning of medically fragile patients with neurological and/or orthopedic conditions, representing an added value for ensuring appropriate patient management. This approach improves system efficiency and supports a proactive strategy that promotes the appropriate use of resources.
Подробное описание
This is a prospective, observational, non-profit study.
Primary Objective:
To compare functional and cognitive test results at discharge from "La Residenza" rehabilitation center (Rodello - CN- Italy) with remote assessments at patients' homes, demonstrating that Timed Up and Go (TUG) and GPCog tests, validated in-person, can be reliably administered via telemedicine.
Secondary Objectives:
To monitor motor and cognitive function remotely at 3, 6, and 12 months after discharge, assessing clinical course and disease progression, and evaluating patient condition as stable, improved, or deteriorated.
Study Timeline and Sample Size:
Recruitment is expected from September 2025 to March 2026, with last follow-up in March 2027 and an additional 6 months for data analysis and publication. A total of 100 patients (50 orthopedic, 50 neurological) will be enrolled, accounting for a 25% expected loss, based on power calculations for paired t-tests comparing in-person and remote assessments.
Вмешательства
- Другое Telemedicine-Based Functional Monitoring
This intervention provides structured functional monitoring of medically fragile patients with neurological and/or orthopedic conditions using telemedicine. Patients undergo MMSE, Rankin Scale, Barthel Index, TUG, GPCog, and SF-36 assessments at discharge and during follow-up at 3, 6, and 12 months. Patient and caregiver satisfaction with remote monitoring is also evaluated. All remote assessments are performed via the TESI eViSus BioCare® system on mobile devices, allowing early detection of fu
Первичные конечные точки
- Concordance Between In-Person and Telemedicine Assessments of Functional and Cognitive Performance [Срок оценки: 5-10 days after discharge]
Вторичные конечные точки (7)
- Timed Up and Go (TUG) Test Performance [Срок оценки: 3, 6, and 12 months after discharge]
- General Practitioner Assessment of Cognition (GPCog) Score [Срок оценки: 3, 6, and 12 months after discharge]
- Modified Rankin Scale (mRS) [Срок оценки: Baseline and 12 months after discharge]
- Barthel Index for Activities of Daily Living [Срок оценки: Baseline and 12 months after discharge]
- SF-36 Composite Scores (Physical and Mental Component Summaries) [Срок оценки: At discharge and 12 months after discharge]
- Patient Satisfaction With Remote Monitoring [Срок оценки: 3, 6, and 12 months after discharge]
- Caregiver Satisfaction With Remote Monitoring [Срок оценки: 3, 6, and 12 months after discharge]
Критерии участия
Критерии включения
- Adult medically fragile patients with one of the following neurological conditions: mild-to-moderate stroke (Rankin ≤ 3), Multiple Sclerosis (EDSS ≤ 6.5), Parkinson's disease or parkinsonisms, neuromuscular diseases; or orthopedic conditions: femur, pelvis, or humerus fracture.
- Able to walk independently, with or without assistive devices.
- Adequate cognitive function (MMSE ≥ 24).
- Patient or caregiver owns and can use a mobile device with internet/data connection.
- Presence of a cognitively capable, cooperative caregiver willing to participate in the study.
Критерии исключения
- Patients with severe neurological or orthopedic conditions who cannot walk independently, even with assistive devices.
- Patients with moderate or severe cognitive impairment (MMSE < 24).
- Patients with Barthel Index > 60.
- Patients or caregivers unable to use a mobile device or without internet/data connection.
- Patients without a cooperative, cognitively capable caregiver.
Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.
Здоровые добровольцы: Нет
Дизайн исследования
- Модель наблюдения
- Когортное
Центры проведения
Италия · 1 центр
- Azienda Sanitaria Locale CN2 Alba-Bra, Ospedale Michele e Pietro Ferrero — Verduno
Публикации
- Feeney J, Savva GM, O'Regan C, King-Kallimanis B, Cronin H, Kenny RA. Measurement Error, Reliability, and Minimum Detectable Change in the Mini-Mental State Examination, Montreal Cognitive Assessment, and Color Trails Test among Community Living Middle-Aged and Older Adults. J Alzheimers Dis. 2016 May 31;53(3):1107-14. doi: 10.3233/JAD-160248. PMID 27258421
- Giavarina D. Understanding Bland Altman analysis. Biochem Med (Zagreb). 2015 Jun 5;25(2):141-51. doi: 10.11613/BM.2015.015. eCollection 2015. PMID 26110027
- Viglino G, Neri L, Barbieri S, Tortone C. Peritoneal dialysis training performed remotely: results and comparison with Home Training. Clin Exp Nephrol. 2023 Jan;27(1):72-78. doi: 10.1007/s10157-022-02276-z. Epub 2022 Sep 21. PMID 36129554
- Brodaty H, Pond D, Kemp NM, Luscombe G, Harding L, Berman K, Huppert FA. The GPCOG: a new screening test for dementia designed for general practice. J Am Geriatr Soc. 2002 Mar;50(3):530-4. doi: 10.1046/j.1532-5415.2002.50122.x. PMID 11943052
- van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, Kanekiyo M, Li D, Reyderman L, Cohen S, Froelich L, Katayama S, Sabbagh M, Vellas B, Watson D, Dhadda S, Irizarry M, Kramer LD, Iwatsubo T. Lecanemab in Early Alzheimer's Disease. N Engl J Med. 2023 Jan 5;388(1):9-21. doi: 10.1056/NEJMoa2212948. Epub 2022 Nov 29. PMID 36449413
- de Joode SGCJ, Kalmet PHS, Fiddelers AAA, Poeze M, Blokhuis TJ. Long-term functional outcome after a low-energy hip fracture in elderly patients. J Orthop Traumatol. 2019 Apr 11;20(1):20. doi: 10.1186/s10195-019-0529-z. PMID 30976999
Идентификаторы
NCT: NCT07299344 · AFTER